A comprehensive view of gsk group (glaxosmithkline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Australia Patent: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT Files Application for 'PHARMACEUTICAL COMPOUND'
Published:
December 08, 2023
by Australian Government
|
GlaxoSmithKline reports new global analysis across five cities shows inequities in adult immunisation uptake; findings signal need to redesign local and national policy interventions
Published:
December 07, 2023
by Targeted News Service (Press Releases)
|
INTERNATIONAL PATENT: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED FILES APPLICATION FOR "USE OF TNF-ALPHA BINDING PROTEINS AND IL-7 BINDING PROTEINS IN MEDICAL TREATMENT"
Published:
December 04, 2023
by U.S. Fed News
|
GlaxoSmithKline releases results from a global survey showing widespread misconceptions about shingles among adults 50 and over, despite high public interest in the disease; survey indicated gaps in understanding on disease transmission and recurrence
Published:
December 01, 2023
by Targeted News Service (Press Releases)
|
State Intellectual Property Office of China Publishes GlaxoSmithKline Biologicals's Patent Application for Pentavalent Vaccine Against Neisseria Meningitidis Comprising Synthetic Men a Antigens
Published:
December 01, 2023
by Chemical Patent News
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count